Going on the Regenmed Investor Day where their talking about surrogate endpoints.
C-Pulse has meaningful clinical endpoints and exceeding them by miles.
As far as Im concerned Im ruling stem cells out of the HF equation.
For some reason, probably many reasons humans evolved to use scar tissue not regeneration.
Stem cells are a mechanism of regeneration but they obviously have systems that sit within them and they sit within systems that sit within other interrelated systems. You've got a hell of a lot of science to understand to make them work. Beyond my lifetime especially since surrogate endpoints aren't going to bring in private investors.
C-Pulse comes in at a much higher systems level. One overriding system already largely understood.
The picture on C-Pulse is getting clearer.
Stem cells and the like aren't even in the foreseeable future.
- Forums
- ASX - By Stock
- SHC
- $SSH - last opportunity ?
$SSH - last opportunity ?, page-11
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)